Amoxicillin and Clavulanate Potassium for Oral Suspension USP

Teva Pharmaceuticals USA, Inc has recalled Amoxicillin and Clavulanate Potassium for Oral Suspension USP, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on November 12, 2025 and was initiated on October 13, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Amoxicillin and Clavulanate Potassium for Oral Suspension USP, with approximately 4680 cartons affected. The company behind the recall is Teva Pharmaceuticals USA, Inc, based in Parsippany, NJ. The FDA describes the product as: “Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany,…”

Why was Amoxicillin and Clavulanate Potassium for Oral Suspension USP recalled?

According to the FDA, the stated reason for the recall is: “Subpotent drug; Clavulanate Potassium component.” In plain terms, this recall relates to a potency or effectiveness issue.

This recall means the medicine may be stronger or weaker than its label says, or may not release its ingredient the way it should. That matters because too little medicine may not treat the condition, and too much can cause side effects. Anyone taking an affected product is generally advised to consult their pharmacist or doctor about a replacement.

What should you do?

If you think you may have bought Amoxicillin and Clavulanate Potassium for Oral Suspension USP, compare it against the product description and identifying codes (Lot # 100062316, Exp Date: 01/2026) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Teva Pharmaceuticals USA, Inc or your local health authority.

About this recall

This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.